dragon
Scopus Index (2025)

Medical journal of wuhan university

Medical journal of wuhan university (ISSN:1671-8852) is a monthly peer-reviewed scopus-indexed journal from 2001 to present. The publisher of this journal is Science China Press. Medical journal of wuhan university committed to gathering and disseminating excellent research achievements. The journal welcomes all types of General Medicine journal includes Medicine,Pharmacy, Bio-Chemistry, Psychology,Public Health Etc.

Medical journal of wuhan university

Submission Deadline

  • ( Vol 46 , Issue 06 ) | 16 Aug 2025

    Day
    Hour
    Min
    Sec

Publication Date

  • ( Vol 46 , Issue 05 ) | 31 Jul 2025

Aim And Scope

Medical journal of wuhan university

General Medicine, Pharmacy, Bio-Chemistry, Psychology Sciences and Public health:

Anatomy, Physiology, Biochemistry, Pharmacology, Pathology, Forensic medicine, Microbiology, Community Medicine, Otorhinolaryngology, Internal Medicine, General Surgery, Obstetrics and Gynecology, Radiology, Pulmonary Medicine, Dermatology and Venereal diseases, Infectious Diseases, Anaesthesia, Cancer research, Neurosurgery, Orthopedics, Gastroenterology, Neurology, Nephrology, Medical education, Orthopaedics, Paediatrics, Reproduction, Cardiology, Diabetes, Surgery, Nursing, Otolaryngology, Dental, Psychology, Anesthesiology, Dermatology,
Endocrinology, Hepatology, Urology, Venereology, Psychiatry, Biotechnology, Pharmacy, ENT, Pharmaceutical Chemistry, Pharmaceutical Analysis, Pharmaceutics, Pulmonology, Pharmacognosy, Pharmaceutical, Phatmaceutical Technology, Biopharmaceutics, Pharmacokinetics Pharmacodynamics, Industrial Pharmacy, Drug Design, Quality Assurance, Drug Regulatory Affairs, Phytochemistry, Drug Delivery Systems, Pharmaceutical Nanotechnology, Pharmaceutical Microbiology, Hospital Pharmacy, Clinical Pharmacy, Pharmacy Practice, Drug Discovery, Drug Metabolism, Toxicology, Clinical Research, Pharmacogenomics, Phrmacoinformatics, Pharmacovigilance, Life Sciences like Chemistry,
Biomedical Sciences, Microbiology, Immunology, Forensic, Epidemiology, Oncology, Biomedicine, Dentistry, Physiotherapy, Gynaecology, Dermatoepidemiology, Neuroscience, Ophthalmology, Sexology, Osteology, Kinesiology, Angiology/Vascular Medicine, Critical care Medicine, Haematology, Infectious Diseases and Vaccinology, Bariatrics, Pharmacy and Nursing, Pharmacognosy and Phytochemistry, Radiobiology, Clinical immunology, Clinical and Hospital Pharmacy, Cell Biology, Genomics and Proteomics, Healthcare Services, Healthcare Management, Bioinformatics and Biotechnology, Geriatric Medicine,

Latest Paper Here

Medical journal of wuhan university
Effects of supramolecular salicylic acid on AMPK/mTOR pathway and autophagy in rats with acne model

The phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway regulates cell proliferation, differentiation, and migration, along with angiogenesis and metabolism. Additionally, it could mediate skin development and homeostasis. There is much evidence to suggest that dysregulation of PI3K/Akt pathway is frequently associated with several human cutaneous malignancies like malignant melanoma (MM), basal cell carcinoma (BCC), and cutaneous squamous cell carcinoma (SCC), as well as their poor outcomes. Nevertheless, emerging roles of PI3K/Akt pathway cascade in a group of co

A controlled study of collagen type ⅩⅦ combined with fractional CO2 laser in the treatment of alopecia areata

Alopecia areata (AA) is a non-scarring autoimmune disease requiring long-term treatments. Topical, intralesional or systemic corticosteroids are the first option. However, considering the risk of skin atrophy and the possible lack of clinical response, new treatment options are urgently needed. A fractional carbon dioxide laser (FCL) has been proven to be effective alone or in combination with other drugs. However, no study has ever evaluated the association between FCL and topical tacrolimus. We report three cases of AA resistant to corticosteroids for at least 12 months, treated with topi

Therapeutic efficacy of 308 nm excimer laser and recombinant type Ⅲ and type ⅩⅦ humanized collagen in the treatment of vitiligo

Our purpose was to demonstrate the efficacy of the 308-nm excimer laser for treatment of psoriasis. This study was a multicenter open trial from 5 dermatology practices (one university-based and 4 private practices). Up to 30 patients per center with stable mild to moderate plaque-type psoriasis constituted the study population. Patients received 308-nm ultraviolet B doses to affected areas. The initial dose was based on multiples of a predetermined minimal erythema dose. Subsequent doses were based on the response to treatment. Treatments were scheduled twice weekly for a total of 10 treat

ALA-PDT treatment for anal condyloma acuminatum complicated with AIDS: Two cases report and literature review

Highly antiretroviral therapy (HAART) used in Human Immunodeficiency Virus (HIV) treatment may prolong the life span of people living with HIV/Acquired Immune Deficiency Syndrome (AIDS) but may also induce the onset of autoimmune disorders. However, HIV-associated systemic sclerosis (SSc) is an extremely rare occurrence, and only four case reports and two studies documenting this association have been reported to date. We report a rare case of HIV-associated SSc who was referred to us for pain management in her mandibular teeth. A 44-year-old female patient diagnosed with HIV-associated SSc

Manifestations in alopecia areata and androgenetic alopecia as visualized by high-frequency ultrasound

Hair-loss diseases comprise heterogenous conditions with respective pathophysiology and clinicopathological characteristics. Major breakthroughs in hair follicle biology and immunology have led to the elucidation of etiopathogenesis of non-scarring alopecia (e.g., alopecia areata, AA) and cicatricial alopecia (e.g., lichen planopilaris, LPP). High-throughput genetic analyses revealed molecular mechanism underlying the disease susceptibility of hair loss conditions, such as androgenetic alopecia (AGA) and female pattern hair loss (FPHL). Hair loss attracted public interest during the COVID-1

MJWU